ViiV Healthcare, a GlaxoSmithKline (GSK) joint venture, makes 17 prescription HIV medicines, including the long-acting treatment cabotegravir, which was first approved in the US in January 2021.
Sold as Cabenuva, it has been available on the NHS as a combination treatment with another drug since April last year, and is injected into the patient's buttocks in hospital every two months. This is an alternative to taking a daily tablet to stop the HIV virus attacking the immune system, leading to Aids.
Deborah Waterhouse, the Viiv chief executive, said: "What patients are saying now is 'we really love the new medicines you have launched, but can there be a longer period between administration so that we only have to go to the clinic three or four times a year, or can we administer at home?' That is obviously what we are aiming to deliver and that is powering our growth."
This story is from the September 29, 2023 edition of The Guardian.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the September 29, 2023 edition of The Guardian.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
The Filter Cast-iron alternatives to Le Creuset for less
Le Creuset's colourful pans have long topped the wishlists of amateur and professional cooks.
Money hacks How to find a pet-sitter you can trust
Unless you have family, a friend or a neighbour who can care for your pet when you're away, you'll need to find a pet-sitter you can trust.
Pensions An A to Z of how to save for your retirement
Everything you need to know to plan for your future and make the most of your finances. Rupert Jones and Hilary Osborne report
'A fork in the road' AI's bid to help on laundry days at Europe's tech summit
This year's Web Summit in Lisbon was all about artificial intelligence and a robot sorting laundry.
Brexit So how could Labour improve EU ties for the sake of growth?
The Bank of England governor, Andrew Bailey, said this week that Brexit had undermined the UK's economy, and urged the government to improve relations with the EU for the sake of growth.
Aviation Flying taxis: destined never to take off?
In a dreary November day in the Cotswolds, the VX4 - a cross between a plane and a helicopter - rose from an airport runway, hovered a few feet off the ground and set back down.
Property firm back in profit as workers return to offices
One of Britain's biggest property developers has provided further evidence of the return to office working, saying occupancy in its central London offices is at an all-time high and the value of its portfolio has returned to growth.
Analysis Summer of dark warnings from the Treasury may have cast a shadow on growth
It was hardly surprising that the chancellor, Rachel Reeves, declared herself \"not satisfied\" with the news that the UK's GDP expanded by a measly 0.1% in the three months to September.
Contracting GDP adds to German woes as general election looms
Germany's looming general election will be fought against the backdrop of a stagnating economy, the European Commission has forecast, with GDP expected to have contracted in 2024.
UK economy slows amid jitters over Labour budget
The UK economy slowed to a near-standstill in the third quarter as uncertainty around Labour's first budget and high interest rates weighed on business and consumer spending.
